Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2024

20-02-2024 | Vacuum Therapy | Image of the Month

Combine Endoluminal Vacuum-Assisted Closure with Basement Membrane Graft for the Treatment of Gastrointestinal Cutaneous Fistula

Authors: Gen Hu, Wei-dong Zhong, Li-Ying Zhang, Jian Zhang, Guo-yi Shao

Published in: Digestive Diseases and Sciences | Issue 4/2024

Login to get access

Excerpt

A 59-year-old male patient was diagnosed of anastomotic cutaneous fistulas on the 10th day after stomal retraction with sinus tracts 5 cm and 2 cm in length, respectively. The fistula did not heal using suture, fibrin glue, and cyanoacrylate glue [1, 2]. We then cut the basement membrane graft (Antisan, Zhuo Ruan Medical) into suitable shape and inserted it into the sinus (Fig. 1a), together with a self-made bullet-shaped endoluminal vacuum-assisted closure device (Fig. 1b). After one week of treatment, the sinus tract was closed (Fig. 1c). A 66-year-old male patient developed two gastrocutaneous fistulas 8 days after left hemicolectomy and partial gastrectomy. After 3 months of treatment with negative pressure wound therapy [3], the sinus tract was reduced to 2 cm in length and 2 mm in diameter (Fig. 2a), but was difficult to close. Eventually, the sinus were closed after 9 days of treatment with the combination of negative pressure and basement membrane as described above (Fig. 2b).
Literature
1.
go back to reference Metcalf C. Considerations for the management of enterocutaneous fistula. Br J Nurs. 2019;28:S24–S31.CrossRefPubMed Metcalf C. Considerations for the management of enterocutaneous fistula. Br J Nurs. 2019;28:S24–S31.CrossRefPubMed
2.
go back to reference Kamada T, Ohdaira H, Nakashima K, Nishide R, Takahashi J, Ito E et al. Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study. BMC Gastroenterol. 2022;22:486.CrossRefPubMedPubMedCentral Kamada T, Ohdaira H, Nakashima K, Nishide R, Takahashi J, Ito E et al. Risk factors for refractory enterocutaneous fistula following button jejunostomy removal and its treatment using a novel extraperitoneal approach in patients with oesophageal cancer: a retrospective cohort study. BMC Gastroenterol. 2022;22:486.CrossRefPubMedPubMedCentral
3.
go back to reference Vignali A, De Nardi P. Endoluminal vacuum-assisted therapy to treat rectal anastomotic leakage: A critical analysis. World J Gastroenterol. 2022;28:1394–1404.CrossRefPubMedPubMedCentral Vignali A, De Nardi P. Endoluminal vacuum-assisted therapy to treat rectal anastomotic leakage: A critical analysis. World J Gastroenterol. 2022;28:1394–1404.CrossRefPubMedPubMedCentral
Metadata
Title
Combine Endoluminal Vacuum-Assisted Closure with Basement Membrane Graft for the Treatment of Gastrointestinal Cutaneous Fistula
Authors
Gen Hu
Wei-dong Zhong
Li-Ying Zhang
Jian Zhang
Guo-yi Shao
Publication date
20-02-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08267-2

Other articles of this Issue 4/2024

Digestive Diseases and Sciences 4/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine